baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out PHARM/ DE000SY2P6K3 /

29/07/2024 09:01:36	Chg.0.000	Bid22:00:36	Ask22:00:36	Underlying	Strike price	Expiration date	Option type
0.140EUR	0.00%	- Bid Size: -	- Ask Size: -	Pharming Group	0.6436 EUR	31/12/2078	Call

GlobeNewswire 03/06 Pharming Group to participate in June investor conferences

GlobeNewswire 21/05 Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders

GlobeNewswire 20/05 Pharming Group to participate in May investor conference

GlobeNewswire 08/05 Pharming Group reports first quarter 2024 financial results and provides business update

GlobeNewswire 24/04 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...

GlobeNewswire 08/04 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

GlobeNewswire 03/04 Pharming Group to participate in April investor conferences

GlobeNewswire 14/03 Pharming Group reports fourth quarter and full year 2023 financial results

GlobeNewswire 29/02 Pharming Group to report fourth quarter and full year 2023 financial results on March 14

GlobeNewswire 08/02 Pharming Group to participate in February investor conferences

GlobeNewswire 08/01 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update

GlobeNewswire 13/12/2023 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...

GlobeNewswire 21/11/2023 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...

GlobeNewswire 13/11/2023 Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Acc...

GlobeNewswire 01/11/2023 Pharming Group to participate in November investor conferences

GlobeNewswire 26/10/2023 Pharming Group reports third quarter 2023 financial results

GlobeNewswire 12/10/2023 Pharming Group to report third quarter 2023 financial results on October 26

GlobeNewswire 25/09/2023 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders

GlobeNewswire 10/01/2022 Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene The...

GlobeNewswire 04/11/2021 Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Upd...

GlobeNewswire 04/08/2021 Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Up...

GlobeNewswire 29/07/2021 Oncorus Expands its Board with Appointment of Barbara Yanni

GlobeNewswire 01/07/2021 Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo ...

GlobeNewswire 20/01/2021 Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors

GlobeNewswire 09/01/2019 Global Hereditary Hematological Disorders Drug Development Pipeline Review 2018

Soc. Generale Knock-Out PHARM/ DE000SY2P6K3 /

If you wish to receive reply to your feedback, please provide your email address.